Brown Brothers Harriman & Co’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18
Closed -$1.83K 1833
2025
Q4
$1.83K Buy
+18
New +$1.45K ﹤0.01% 1737
2025
Q3
Sell
-18
Closed -$957 1697
2025
Q2
$957 Buy
+18
New +$914 ﹤0.01% 1492
2024
Q2
Sell
-293
Closed -$20.2K 1184
2024
Q1
$20.2K Hold
293
﹤0.01% 894
2023
Q4
$21.7K Hold
293
﹤0.01% 841
2023
Q3
$20K Buy
+293
New +$24.9K ﹤0.01% 843
2022
Q4
Sell
-6
Closed 1338
2022
Q3
$0 Buy
+6
New +$247 ﹤0.01% 1526
2021
Q3
Sell
-250
Closed -$31 1182
2021
Q2
$31 Hold
250
﹤0.01% 742
2021
Q1
$33 Sell
250
-190
-43% -$26K ﹤0.01% 708
2020
Q4
$58K Hold
440
﹤0.01% 638
2020
Q3
$45K Hold
440
﹤0.01% 590
2020
Q2
$38K Buy
440
+190
+76% +$15.2K ﹤0.01% 605
2020
Q1
$15K Hold
250
﹤0.01% 665
2019
Q4
$23K Sell
250
-454
-64% -$39.9K ﹤0.01% 779
2019
Q3
$64K Hold
704
﹤0.01% 605
2019
Q2
$83K Buy
704
+4
+0.6% +$403 ﹤0.01% 518
2019
Q1
$61K Buy
700
+450
+180% +$38.3K ﹤0.01% 549
2018
Q4
$16K Hold
250
﹤0.01% 648
2018
Q3
$20K Hold
250
﹤0.01% 614
2018
Q2
$15K Hold
250
﹤0.01% 619
2018
Q1
$10K Hold
250
﹤0.01% 659
2017
Q4
$13K Hold
250
﹤0.01% 717
2017
Q3
$12K Buy
+250
New +$10.1K ﹤0.01% 647

Other funds holding EXAS

Brown Brothers Harriman & Co's EXAS Position: Q1 2026 in Review

Brown Brothers Harriman & Co sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 18 shares — an estimated $1.83K sold.

Brown Brothers Harriman & Co first reported a position in EXAS in Q3 2017 and held it in 22 quarters. The position peaked at $83K in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Brown Brothers Harriman & Co reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 18 Exact Sciences shares in Q1 2026, an estimated $1.83K.
  • Brown Brothers Harriman & Co first reported a position in Exact Sciences in Q3 2017 and held it in 22 quarters.
  • Brown Brothers Harriman & Co's Exact Sciences position peaked at $83K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.